Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/UROGEN-PHARMA-LTD-34790020/news/UroGen-Pharma-Ltd-Announces-Positive-Topline-Data-From-its-Phase-3-Trials-ATLAS-and-ENVISION-studyi-44442103/?utm_source=whatsapp&utm_medium=social&utm_campaign=share